Antiretrovirale Medikamente und Schwangerschaft [Antiretroviral therapy and pregnancy].

Details

Serval ID
serval:BIB_32ECFD3572BC
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Antiretrovirale Medikamente und Schwangerschaft [Antiretroviral therapy and pregnancy].
Journal
Therapeutische Umschau. Revue Thérapeutique
Author(s)
Wunder D., Evison J.M.
ISSN
0040-5930 (Print)
ISSN-L
0040-5930
Publication state
Published
Issued date
2005
Volume
62
Number
1
Pages
37-42
Language
german
Notes
Publication types: English Abstract ; Journal Article ; Review
Abstract
Whereas the perinatal transmission rate with untreated HIV positive women is around 30%, the results of Pediatric AIDS Clinical Trials Group in 1994 showed a reduction by nearly 70% with Zidovudin chemoprophylaxis. The transmission rate can even be reduced to under 2%, if a cesarean section before onset of labour and before premature rupture of membranes is done in addition. An individualized, optimal antiretroviral combination therapy, ideally introduced in the second trimenon (in special cases even already in the first trimenon), is of great importance. As a further strategy of prevention of perinatal transmission, intravenous Zidovudin chemoprophylaxis should be given in addition to the mother during labour and to the newborn during the first six weeks of life. Besides very few exceptions, long-term data after intrauterine administration of antiretroviral therapy do not show any teratogen or other long term consequences to date. The situation in developing countries is very critical with still high transmission rates because of the lack of antiretroviral therapy due to logistical reasons and costs and the need of breastfeeding. For these reasons, more and more feasible short protocols are developed with at least fifty percent reduction of neonatal transmission rates.
Keywords
Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use, Anti-Retroviral Agents/administration & dosage, Anti-Retroviral Agents/adverse effects, Female, HIV Infections/embryology, HIV Infections/prevention & control, Humans, Infectious Disease Transmission, Vertical/prevention & control, Maternal-Fetal Exchange/drug effects, Physician's Practice Patterns, Practice Guidelines as Topic, Pregnancy, Pregnancy Complications, Infectious/drug therapy, Risk Assessment/methods, Risk Factors, Treatment Outcome, Women's Health, Zidovudine/administration & dosage, Zidovudine/adverse effects
Pubmed
Create date
19/03/2012 11:25
Last modification date
20/08/2019 14:18
Usage data